The Human Research Ethics Committee (HREC) has given Radiopharm Theranostics its stamp of approval to begin first-in-human phase-one dose...

Radiopharm Theranostics has negotiated an expanded agreement with TerThera for the supply of the terbium-161 (Tb-161) isotope to continue...

A positive meeting with the United States Food and Drug Administration (USFDA) has boosted Radiopharm Theranostics’ approval prospects...

A pancreatic cancer treatment developed by ASX-listed Radiopharm Theranostics has been granted crucial orphan drug designation by the...